![](bg5.png)
Farnoosh Mohammadi and Iman Tavakoli
186 THE ORAL AND MAXILLOFACIAL MANIFESTATION AND SURGICAL CONSIDERATION BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS
REFERENCES
Alpoz A, Coker M, Celen E, Ersin NK, Gokcen D, Diggelenc
OP, Jan G, Huijmansc M (2006). The oral manifestations of
Maroteaux-Lamy syndrome (mucopolysaccharidosis VI):
A case report. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod.101:632-7.
Azevedo AC, Schwartz L IV, Kalakun L Brustolin S, Burin MG,
Beheregaray AP, Leistner S, Giugliani C, Rosa M, Barrios P,
Marinho D, Esteves P, Valadares E, Boy R, Horovitz D, Mabe P,
da Silva LC, de Souza IC, Ribeiro M, Martins AM, Palhares D,
Kim CA, Giugliani R (2004). Clinical and biochemical study of
28 patients with mucopolysaccharidosis type VI. Clin Genet.
66:208–13.
Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E,
Bajbouj M, Whybra C, Kohlschütter A, Kampmann C, Beck M
(2005). Cumulative incidence rates of the mucopolysacchari-
doses in Germany. J Inherit Metab Dis. 28:1011-17.
Baum H, Dodgson KS, Spencer B (1959). The assay of aryl-
sulphatase A and B in human urine. Clin Chim Acta;4:453-5.
Cavaleiro RM, Pinheiro Md, Pinheiro LR, Tuji FM, Feio Pdo S,
de Souza IC, Feio RH, de Almeida SC, Schwartz IV, Giugliani
R, Pinheiro JJ, Santana-da-Silva LC (2013). Dentomaxillofa-
cial manifestations of mucopolysaccharidosis VI: clinical and
imaging ndings from two cases, with an emphasis on the
temporomandibular joint.116: 141-8.
Fonseca FR, de Santana Sarmento DJ, Vasconcelos Medeiros
PF, Diniz DN, dos Santos MT (2014). Patients with mucopoly-
saccharidosis have tendencies towards vertical facial growth. J
Oral Maxillofac Surg.72: 2539-46.
Litjens T, Baker EG, Beckmann KR, Morris CP, Hopwood JJ,
Callen DF (1989). Chromosomal localization of ARSB, the gene
for human N-acetylgalactosamine-4-sulphatase. Hum Genet.
82:67-8.
Malm G, Lund AM, Mansson JE, Heiberg A (2008). Mucopoly-
saccharidoses in the Scandinavian countries: incidence and
prevalence. Acta Paediatr. 97:1577-81.
Maroteaux P, Leveque B, Marie J, Lamy M (1963). A new
dysostosis with urinary elimination of chondroitin sulfate B.
Presse Med. 71:1849–52.
McGill JJ, Inwood AC, Coman DJ, Lipke ML, de Lore D, Swie-
dler SJ, Hopwood JJ (2010). Enzyme replacement therapy for
mucopolysaccharidosis VI from 8 weeks of age--a sibling con-
trol study. Clin Genet. 77:492-8.
Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999). Preva-
lence of lysosomal storage disorders. JAMA. 281:249-54.
Neufeld EF, Muenzer J (1995). The mucopolysaccharidoses. The
metabolic and molecular bases of inherited disease. New York:
McGraw-Hill. 2465-94.
Roberts MW, Barton NW, Constantopoulos G, Butler DP, Dona-
hue AH (1984). Occurrence of multiple dentigerous cysts in
a patient with the Maroteaux-Lamy syndrome (mucopoly-
saccharidosis, type VI). Oral Surg Oral Med Oral Pathol Oral
Radiol Endod. 58:169-75.
Valayannopoulos V, Nicely H, Harmatz P, Turbeville S (2010).
Mucopolysaccharidosis VI, Orphanet. J Rare Dis. 5:5–20.
Wiedemann HR, Kunze J, Grosse FR, Dibbern H (1992). An
atlas of clinical syndromes (a visual aid to diagnosis). Ayles-
bury: Wolfe Publishing Co. p. 58.